CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −13,548 | $42.63 | $578K | 832,857 |
| 2025-10-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −1,552 | $43.03 | $67K | 831,305 |
| 2025-07-11 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,884 | $14.51 | $230K | 846,405 |
| 2025-04-11 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,319 | $12.19 | $187K | 862,289 |
| 2025-02-13 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +570,000 | 570,000 | ||
| 2025-01-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −18,333 | $9.06 | $166K | 877,608 |
| 2024-10-11 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,271 | $13.52 | $206K | 895,941 |
Page 2 of 2 · 27 trades